1. Home
  2. AURA vs PCT Comparison

AURA vs PCT Comparison

Compare AURA & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

N/A

Current Price

$7.11

Market Cap

631.6M

Sector

Health Care

ML Signal

N/A

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

N/A

Current Price

$1.71

Market Cap

556.5M

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
AURA
PCT
Founded
2007
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Environmental Services
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
631.6M
556.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
AURA
PCT
Price
$7.11
$1.71
Analyst Decision
Strong Buy
Buy
Analyst Count
6
5
Target Price
★ $16.60
$6.40
AVG Volume (30 Days)
748.9K
★ 8.6M
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 30.86
EPS
N/A
★ N/A
Revenue
N/A
★ $8,355,000.00
Revenue This Year
N/A
$269.48
Revenue Next Year
N/A
$262.99
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.73
$1.60
52 Week High
$9.54
$14.20

Technical Indicators

Market Signals
Indicator
AURA
PCT
Relative Strength Index (RSI) 57.34 26.91
Support Level $6.65 $1.60
Resistance Level $7.83 $3.53
Average True Range (ATR) 0.41 0.35
MACD 0.11 -0.03
Stochastic Oscillator 60.05 6.20

Price Performance

Historical Comparison
AURA
PCT

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

Share on Social Networks: